Trials / Terminated
TerminatedNCT01342016
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
A Randomized, Double-blind Double Dummy, Parallel Control and Multi-center Clinical Trial to Compare the Efficacy and Safety of Tacrolimus Capsules in Treatment of Lupus Nephritis With Leflunomide Tablets
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 84 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the efficacy and safety of tacrolimus capsules with leflunomide tablets in the treatment of lupus nephritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tacrolimus capsule | oral |
| DRUG | tacrolimus placebo | oral |
| DRUG | leflunomide tablet | oral |
| DRUG | leflunomide placebo | oral |
| DRUG | prednisone | oral |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2013-05-01
- Completion
- 2013-05-01
- First posted
- 2011-04-26
- Last updated
- 2014-10-17
Locations
12 sites across 1 country: China
Source: ClinicalTrials.gov record NCT01342016. Inclusion in this directory is not an endorsement.